Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to $98.8 million.

  • P3 Health Partners' Cash from Financing Activities rose 68994.37% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.6 million, marking a year-over-year increase of 1849.72%. This contributed to the annual value of $98.8 million for FY2024, which is 155.58% down from last year.
  • According to the latest figures from FY2024, P3 Health Partners' Cash from Financing Activities is $98.8 million, which was down 155.58% from $100.3 million recorded in FY2023.
  • P3 Health Partners' Cash from Financing Activities' 5-year high stood at $100.3 million during FY2023, with a 5-year trough of $11.4 million in FY2022.
  • Over the past 5 years, P3 Health Partners' median Cash from Financing Activities value was $34.8 million (recorded in 2020), while the average stood at $54.0 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 4536.26% in 2020, then surged by 78203.96% in 2023.
  • Annual analysis of 5 years shows P3 Health Partners' Cash from Financing Activities stood at $34.8 million in 2020, then decreased by 28.68% to $24.8 million in 2021, then tumbled by 54.11% to $11.4 million in 2022, then skyrocketed by 782.04% to $100.3 million in 2023, then decreased by 1.56% to $98.8 million in 2024.
  • Its last three reported values are $98.8 million in FY2024, $100.3 million for FY2023, and $11.4 million during FY2022.